The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer-Reference-Cited by-同舟云学术

The branched-chain amino acid transaminase 1 sustains growth of antiestrogen-resistant and ERα-negative breast cancer

Published:2017-03-20 Issue:29 Volume:36 Page:4124-4134
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Thewes V,Simon R,Hlevnjak M,Schlotter M,Schroeter P,Schmidt K,Wu Y,Anzeneder T,Wang W,Windisch P,Kirchgäßner M,Melling N,Kneisel N,Büttner R,Deuschle U,Sinn H P,Schneeweiss A,Heck S,Kaulfuss S,Hess-Stumpp H,Okun J G,Sauter G,Lykkesfeldt A E,Zapatka M^ORCID,Radlwimmer B^ORCID,Lichter P,Tönjes M

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/onc201732.pdf

Reference51 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136: E359–E386.

2. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747–752.

3. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001; 98: 10869–10874.

4. Early Breast Cancer Trialists' Collaborative G. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365: 1687–1717.

5. Jordan VC, O'Malley BW . Selective estrogen-receptor modulators and antihormonal resistance in breast cancer. J Clin Oncol 2007; 25: 5815–5824.

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fueling the fight against cancer: Exploring the impact of branched-chain amino acid catalyzation on cancer and cancer immune microenvironment;Metabolism;2024-12

2. Identify BCAT1 plays an oncogenic role and promotes EMT in KIRC via single cell RNA-seq and experiment;Frontiers in Oncology;2024-09-11

3. HuR promotes castration-resistant prostate cancer progression by altering ERK5 activation via posttranscriptional regulation of BCAT1;Journal of Translational Medicine;2024-02-18

4. A gold-based inhibitor of oxidative phosphorylation is effective against triple negative breast cancer;Biomedicine & Pharmacotherapy;2024-01

5. The Alliance Between the German Cancer Research Center and Bayer: A Retrospective of an Innovative Collaboration Model;Handbook of Experimental Pharmacology;2024